Eloralintide
A Study of Eloralintide (LY3841136) in Chinese Participants With Obesity or Overweight
Eli Lilly · Phase 1 · Completed · Enrollment 30
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Eloralintide | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
Not shown
- Eloralintide: endpoint not reported
- Placebo: endpoint not reported